# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The psychedelics sector received its latest sign of acceptance from Wall Street with famed investor Cathie Wood taking a positi...
HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for inv...
Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC: HAVLF) is purchasing functional mushroom wellness brand Spore Life Sci...
More big names in cannabis are switching to psychedelics.
The Week In Psychedelics:
Contents
Last week in Psychedelics:
The premier gathering of cannabis entrepreneurs and investors in North America returns for an all-day virtual event on June 3-4.
Two of the most prominent companies in the psychedelics space released their financials for the first quarter of 2021.